Lauren E Mueller, Peter P Issa, Mohammad Hosny Hussein, Rami M Elshazli, Muhib Haidari, Youssef Errami, Mohamed Shama, Manal S Fawzy, Emad Kandil, Eman Toraih
BACKGROUND: Radiofrequency ablation (RFA) utilizes minimally invasive high-energy current to precisely ablate tumor cells. It has been utilized in many cancer types including thyroid, lung, and liver cancer. It has been shown to provide adequate ablative margins with minimal complications; however, incomplete RFA may lead to recurrence of tumor. The underlying cellular mechanism and behavior of ablated cancer tissue is poorly understood. METHODS: A systematic review was performed, searching EMBASE, Web of Science, PubMed, and Scopus for studies published up to March 2022 and reported following PRISMA guidelines...
January 29, 2024: Gland Surgery